| Ytd | 24.54% | |
| 1y | 64.24% |
| Open | 26.35 | Prev Close | 26.24 | Low | 26.39 | High | 26.85 | Mkt Cap | 2.16B |
| Vol | 518.04K | Avg Vol | 775.01K | EPS | 2.09 | P/E | 12.75 | Forward P/E | 10.91 |
| Beta | 0.61 | Short Ratio | 6.52 | Inst. Own | 107.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 26.34 | 200-d Avg | 23.37 | 1yr Est | 26.33 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered in
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volume
Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 60.9%
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free R
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagi
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and pri
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and r
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its gr
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results desp
Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and rea
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.63 per share, beating the Zacks
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the anal
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Resul
Allspring Global Investments Holdings LLC increased its holdings in Pediatrix Medical Group, Inc. (N
Shares of Pediatrix Medical Group, Inc. (NYSE: MD - Get Free Report) have received a consensus recom
Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The
Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading pr
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
One of the biggest mistakes investors make is spending all their time looking for what is cheap and
Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the p
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.50 per share which missed the an